Business Wire
-
Seek Labs Unveils BioSeeker
6/10/2025
Seek Labs—a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics—today announced BioSeeker, a next-generation AI discovery engine redefining how the world identifies and treats disease.
-
Bruker Announces Acquisition Of biocrates, A Leader In Mass Spectrometry-Based Quantitative Metabolomics
6/3/2025
Bruker Corporation today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed.
-
hc1 Introduces Outreach Optimization Solution To Drive Laboratory Success
6/3/2025
hc1 introduced today its new Outreach Optimization solution, designed to transform how clinical laboratories expand their outreach programs, strengthen provider relationships, and drive new revenue.
-
Revvity Introduces New IVD Reference Standards For Monitoring Oncology Diagnostic Testing Workflows
6/2/2025
Revvity, Inc. today announced the launch of three Mimix reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from human samples for IVD use.
-
QIAGEN Expands Portfolio For Minimal Residual Disease (MRD) Testing In Oncology With New Strategic Partnerships
6/2/2025
QIAGEN today announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials to support pharma co-development projects for companion diagnostics.
-
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility And Reliability To Labs
5/29/2025
Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen Attune Xenith Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed and accurate insights from critical cellular samples.
-
Scientist.com Adds Trial Insights To Clinical Labs Navigator Solution, Giving Researchers Instant Access To Global Clinical-Trial Intelligence
5/28/2025
Scientist.com, the leading R&D procurement platform for the life sciences, today integrated Trial Insights—its real‑time clinical‑trial analytics tool—into Clinical Labs Navigator.
-
Guardant Health Introduces Nearly A Dozen Groundbreaking Smart Liquid Biopsy Applications For Guardant360 Liquid Test
5/27/2025
Guardant Health, Inc a leading precision oncology company, today announced major new features for the Guardant 360 Liquid test that greatly expand its biomarker identification and cancer subtyping capabilities to help oncologists identify optimal treatment plans.
-
Agilent Unveils The Next Generation In LC-Mass Detection: The InfinityLab Pro iQ Series
5/27/2025
Agilent Technologies Inc today announced the launch of its latest innovation in liquid chromatography (LC)-mass detection: the Agilent InfinityLab Pro iQ Series.
-
Agilent Announces My Green Lab Ecolabel 2.0 For The New Infinity III LC Series
5/20/2025
Agilent Technologies Inc. today announced that the Infinity III LC Series — the company’s latest liquid chromatography (LC) instruments — are the first Agilent instruments to receive the new My Green Lab ACT Ecolabel 2.0, further reinforcing Agilent’s commitment to sustainable scientific innovation.